loading
Oviya MedSafe - Walking with DIA on the Pharmacovigilance road

Dear Well-wishers,

While I take the pleasure of penning this October 2019 edition of Oviya MedSafe‘s newsletter, I thankfully acknowledge those of you who took the time to listen to my 27-minute audio interview to the Drug Information Association (DIA) that was highlighted last month. I sincerely appreciate the positive feedback you personally shared with me and am enthused to update you that the DIA further honoured me by featuring me on the cover page of the month’s issue of Global Forum (a DIA publication), with my podcast being embedded in it.

I had always wanted to write an account on the crucial role of DIA in my professional journey and I believe this could be a right time to reminisce upon my evergreen memories of how DIA enabled the realization of my larger dreams for pharmacovigilance. Interestingly, I had recorded my feelings for DIA as a requested testimonial as early as in 2016, as follows:

As a pharmacovigilance professional, DIA was the first forum that gave me the access to listen to speakers from a variety of organizations and comprehend the interdisciplinary nature of the subject. Much of my fascination with pharmacovigilance could be attributed to the insights I received by participating in DIA Pharmacovigilance Meetings, which indeed played a causal role in me becoming a pharmacovigilance entrepreneur. It has been my pleasure to have been associated with DIA events as a delegate, sponsor and most recently as a Program Committee Member and Moderator of a Panel Discussion session in the DIA India Pharmacovigilance Conference 2016. I am sure I am not exaggerating when I say that DIA has always been and will ever continue to be close to my heart, as an active facilitator of my career growth and my first window to get exposed to the realm of pharmacovigilance. Thank you from the bottom of my heart, DIA!

However, I had not sensed then that it was just the beginning and DIA rather had much more in store for me. Not only did I continue contributing as a Speaker, Session Chair and Program Committee Member to the subsequent DIA India Pharmacovigilance Conferences every year, I was also invited to write an article for Global Forum which later earned me the honorary position of Regional Editor (India) of the DIA publication. Thanks to DIA, I have had enjoyable experiences of collaborating with several doyens in the Healthcare, Pharmaceutical and Life Sciences domains, by getting them onboard as guest authors on different occasions.

The latest distinction that DIA conferred on me is undoubtedly the invitation to represent India in Washington DC at the 2020 edition of the world’s biggest pharmacovigilance conference, namely the Pharmacovigilance and Risk Management Strategies Conference held in the United States of America in January every year. I am eager to present my views on the topic “Post-Approval Pharmacovigilance Obligations for the Industry in India: Current Scenario” which will be part of a session chaired by Dr E Stewart Geary (Senior VP, Chief Medical Officer & Director, Corporate Medical Affairs HQ at Eisai). With my co-speakers Rie Matsui and Stella Xu representing Japan and China respectively, this session will ensure that key pharmacovigilance updates from the Asia Region, especially those of regulatory relevance to the pharmaceutical industry, be shared on a global platform.

I hope I would be able to meet many of you at the conference and engage in productive discussions on the subject. I trust this event could also serve as a forum for us to explore scopes for professional synergies. I am keen to entertain meeting requests in Washington DC during the conference period and in other parts of the USA during the following week. If you are interested in having a dialogue with Oviya MedSafe, I request you to reach out to us as early as possible so that we can freeze the slots on our calendars.

Looking forward to connect through our November 2019 newsletter,

With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)

Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Coimbatore, India
Phone: +91-422-2444442

Director,
Oviya MedSafe UK Ltd,
London, UK
Phone: +44-8452-733839

Web: www.oviyamedsafe.com
Mail: info@oviyamedsafe.com
Follow us on: Facebook, LinkedIn & Twitter

News & Events

View All